Real-World Outcomes in COPD Patients Starting Trixeo (Budesonide/Glycopyrronium/Formoterol) in Spain.

CompletedOBSERVATIONAL
Enrollment

553

Participants

Timeline

Start Date

July 2, 2024

Primary Completion Date

December 16, 2024

Study Completion Date

December 16, 2024

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Trial Locations (15)

Unknown

Research Site, Barcelona

Research Site, Granada

Research Site, Lleida

Research Site, Lugo

Research Site, Madrid

Research Site, Málaga

Research Site, Murcia

Research Site, Ourense

Research Site, Oviedo

Research Site, Palma de Mallorca

Research Site, Santa Cruz de Tenerife

Research Site, Seville

Research Site, Valencia

Research Site, Vitoria-Gasteiz

Research Site, Zaragoza

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY